Trials / Completed
CompletedNCT03434574
Aronia Berry Consumption on Blood Pressure
Evaluation of the Effect of Chokeberry (Aronia Melanocarpa) Polyphenols on Blood Pressure in Prehypertensive Healthy Men and Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Aronia berries are a native North American berry with high naturally occurring anthocyanins among other polyphenols. Based on their polyphenol composition, there is growing interest in the potential for Aronia berries to elicit health promoting cardio-metabolic effects. Specifically, Aronia berry extracts, which provide a concentrated source of polyphenols, may improve blood vessel function. Thus, the primary focus of this project is to evaluate the effects of Aronia berry polyphenols on blood pressure and other biomarkers of cardiovascular disease risk such as endothelial function, arterial stiffness and blood lipids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Identical formulation as the treatment consisting of colored maltodextrin using artificial colors. |
| DIETARY_SUPPLEMENT | Aronia extract | Powdered extract obtained from aronia berries (Aronia melanocarpa). |
Timeline
- Start date
- 2018-02-20
- Primary completion
- 2019-09-12
- Completion
- 2019-09-12
- First posted
- 2018-02-15
- Last updated
- 2019-09-23
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03434574. Inclusion in this directory is not an endorsement.